Pillstats
Tablet

Alprazolam

Alprazolam

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)596
US makers2 labelers
Packages8
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.014$0.028$0.042$0.056Dec 2025Apr 2026Jul 2026
$0.049
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

16K32K48K65K2025 Q12025 Q22025 Q32025 Q42026 Q1
43K
Rx · 2026 Q1
2.7M
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown4SUPPLYING
Pfizer Ireland Pharmaceuticals Unlimited Companyunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.